Clamart, France

Jacqueline Donjon De Saint-Martin


 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2002-2012

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jacqueline Donjon De Saint-Martin: Innovating in HIV Research

Introduction: Jacqueline Donjon De Saint-Martin is a notable inventor based in Clamart, France, recognized for her contributions in the field of HIV research. With a total of three patents to her name, she has made significant strides in developing innovative solutions that advance our understanding and response to HIV-1.

Latest Patents: Jacqueline's most recent patents focus on nucleotide sequences of HIV-1 group O retroviral antigens. These include advancements related to an HIV-1 type O retrovirus protein, as well as natural or synthetic polypeptides and peptides that can be recognized by antibodies isolated from serum resulting from infection by specific HIV-1 type O VAU and O DUR strains. Her work aims to enhance the immunological responses and diagnostic capacities for HIV.

Career Highlights: Jacqueline is an esteemed researcher at the Institut Pasteur, a world-renowned institution dedicated to infectious disease research and public health. Her work at this prestigious laboratory underscores her commitment to addressing some of the most significant challenges in virology today, particularly regarding HIV.

Collaborations: Throughout her career, Jacqueline has collaborated with esteemed colleagues such as Pierre Charneau and Andrew Borman. These collaborations have further enriched her research efforts and contributed to the development of valuable insights in the field of retroviruses and HIV.

Conclusion: As an inventor and researcher, Jacqueline Donjon De Saint-Martin exemplifies dedication and innovation in the fight against HIV. Her patents not only highlight her technical expertise but also her contributions to public health, making her an inspiring figure in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…